Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 365

1.

Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.

Kobayashi A, Kawanishi C, Matsumura T, Kato D, Furukawa R, Kishida I, Hirayasu Y.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1170-2. Epub 2006 May 8.

PMID:
16682107
2.

Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies.

Sechi G, Agnetti V, Masuri R, Deiana GA, Pugliatti M, Paulus KS, Rosati G.

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Aug;24(6):1043-51.

PMID:
11041543
3.

Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.

Aarsland D, Perry R, Larsen JP, McKeith IG, O'Brien JT, Perry EK, Burn D, Ballard CG.

J Clin Psychiatry. 2005 May;66(5):633-7.

PMID:
15889951
4.
5.

Pharmacotherapy of dementia with Lewy bodies.

Fernandez HH, Wu CK, Ott BR.

Expert Opin Pharmacother. 2003 Nov;4(11):2027-37. Review.

PMID:
14596656
6.

Dementia with lewy bodies: therapeutic opportunities and pitfalls.

Henriksen AL, St Dennis C, Setter SM, Tran JT.

Consult Pharm. 2006 Jul;21(7):563-75. Review.

PMID:
16934009
7.

Quetiapine for psychosis in Parkinson's disease versus dementia with Lewy bodies.

Fernandez HH, Trieschmann ME, Burke MA, Friedman JH.

J Clin Psychiatry. 2002 Jun;63(6):513-5.

PMID:
12088163
8.

Neuroleptic malignant syndrome secondary to quetiapine.

Gortney JS, Fagan A, Kissack JC.

Ann Pharmacother. 2009 Apr;43(4):785-91. doi: 10.1345/aph.1L371. Epub 2009 Mar 18. Review.

PMID:
19299325
9.

[Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].

Khaldi S, Kornreich C, Choubani Z, Gourevitch R.

Encephale. 2008 Dec;34(6):618-24. doi: 10.1016/j.encep.2007.11.007. Epub 2008 Apr 2. Review. French.

PMID:
19081460
10.

[A study of neuroleptic malignant syndrome in the presenium and senium].

Suzuki I, Honma H, Watanabe N, Matsubara S, Koyama T.

Seishin Shinkeigaku Zasshi. 1998;100(6):387-97. Japanese.

PMID:
9745353
11.

Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.

Hatch CD, Lund BC, Perry PJ.

Pharmacotherapy. 2001 Aug;21(8):1003-6.

PMID:
11718487
12.

[Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].

Drach LM.

Med Monatsschr Pharm. 2011 Feb;34(2):47-52; quiz 53-4. Review. German.

PMID:
21428015
13.

Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series.

Takahashi H, Yoshida K, Sugita T, Higuchi H, Shimizu T.

Prog Neuropsychopharmacol Biol Psychiatry. 2003 May;27(3):549-53.

PMID:
12691793
14.

Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient.

Bottlender R, Jäger M, Hofschuster E, Dobmeier P, Möller HJ.

Pharmacopsychiatry. 2002 May;35(3):119-21.

PMID:
12107858
15.

The association of neuroleptic sensitivity in Lewy body disease with a false positive clinical diagnosis of Creutzfeldt-Jakob disease.

Lemstra AW, Schoenmaker N, Rozemuller-Kwakkel AJ, van Gool WA.

Int J Geriatr Psychiatry. 2006 Nov;21(11):1031-5.

PMID:
16955430
16.

Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies.

Ballard CG, Perry RH, McKeith IG, Perry EK.

Int J Geriatr Psychiatry. 2005 Sep;20(9):872-5.

PMID:
16116579
17.

Cognitive effects of quetiapine in a patient with dementia with Lewy bodies.

Rice T, Dobry Y, Wang E, Novakovic V, Sher L.

Psychogeriatrics. 2013 Mar;13(1):52-7. doi: 10.1111/j.1479-8301.2012.00414.x.

18.
19.

Agranulocytosis and granulocytopenia associated with quetiapine.

Ruhé HG, Becker HE, Jessurun P, Marees CH, Heeringa M, Vermeulen HD.

Acta Psychiatr Scand. 2001 Oct;104(4):311-3; discussion 313-4.

PMID:
11722307
20.

Efficacy and tolerability of quetiapine in the treatment of behavioral and psychological symptoms of dementia.

Onor ML, Saina M, Aguglia E.

Am J Alzheimers Dis Other Demen. 2006 Dec-2007 Jan;21(6):448-53.

PMID:
17267378

Supplemental Content

Support Center